S Died in Health Policy
Email me when SB 966 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 966. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would create a new permitting system for outsourcing facilities that compound drugs, obligating them to apply to the Department of Health and submit FDA inspection documentation before operating. The Florida Board of Pharmacy would become the sole state regulator, and FDA inspection reports would count as satisfying any state inspection requirement. Facilities that already held a permit before July 1 2026 could keep operating under that permit until it expires or is otherwise changed.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 966
3 free questions a day, no accountHistory
- Died in Health Policy
- Introduced
- Referred to Health Policy; Appropriations Committee on Health and Human Services; Rules
- Filed
Sponsors
- Stan McClain (R) · sponsor
- McClain
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 966 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 966 freeOr ask your AI assistant about SB 966 directly:
Add to Claude, ChatGPT or Cursor